zuhd.news ← Map
DAILY · Yahoo Finance · GER

Bayer Aktiengesellschaft

54.68 EUR −2.25% day

A German group selling prescription drugs, consumer medicines, seeds and crop chemicals, the last largely through Monsanto, bought in 2018. Lawsuits over its Roundup weedkiller have shaped its share price since.

Nov 19 · 54.68 EUR · +25.8% vs the window’s open

Yahoo Finance · GER · daily
the numbers23
whenvaluechange
Oct 20low43.48 EUR
Oct 2144.63 EUR+2.6%
Oct 2244.21 EUR−0.9%
Oct 2343.98 EUR−0.5%
Oct 2645.56 EUR+3.6%
Oct 2746.15 EUR+1.3%
Oct 2846.03 EUR−0.3%
Oct 2947.96 EUR+4.2%
Oct 3050.58 EUR+5.5%
Nov 250.02 EUR−1.1%
Nov 351.84 EUR+3.6%
Nov 454.24 EUR+4.6%
Nov 556.22 EUR+3.7%
Nov 655.58 EUR−1.1%
Nov 956.62 EUR+1.9%
Nov 10high57.08 EUR+0.8%
Nov 1156.76 EUR−0.6%
Nov 1256.56 EUR−0.4%
Nov 1356.52 EUR−0.1%
Nov 1657.00 EUR+0.8%
Nov 1756.14 EUR−1.5%
Nov 1855.94 EUR−0.4%
Nov 19latest54.68 EUR−2.3%

Lately

A US judge approved Bayer's $7.25bn class settlement of claims that Roundup's glyphosate caused non-Hodgkin lymphoma. It binds future claimants too, capping the liability bought with Monsanto in 2018, and pays sick users $10,000 to $165,000 each. The ruling came after the last close on the chart, so it does not explain the rise.

  1. Judge Approves Bayer Settlement

Mentioned in · 1

  1. Judge Approves Bayer Settlement Financial Times News